Charles River will curate for AstraZeneca | February 12, 2018 Issue - Vol. 96 Issue 7 | Chemical & Engineering News
Volume 96 Issue 7 | p. 12 | Concentrates
Issue Date: February 12, 2018

Charles River will curate for AstraZeneca

Department: Business
Keywords: Drug discovery, compound library, high throughput screening

Charles River Laboratories has signed an agreement granting it access to AstraZeneca’s high-throughput screening (HTS) and compound management infrastructure. The research services provider will place scientists at AstraZeneca’s Centre for Lead Discovery in Cambridge, England, where they will manage the drug firm’s compound collection and run HTS with access to liquid handling and automated storage systems.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment